Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2022

Month: June

Request Number: A-2021-002114

Request Summary: The screening acceptance letter(s) from Health Canada to any and all generic drug manufacturer(s) for any and all abbreviated new drug submissions (ANDS) for the following medicinal ingredients which appear on the list of Generic Drug Submissions under review dated March 15, 2022: atorvastatin, levetiracetam, ticagrelor.

Disposition: Disclosed in part

Number of pages: 9

Date modified: